Background. -Previous studies indicate that mortality from acute coronary syndromes is higher in women than in men, especially in case of interventional strategy. Aim. -To assess whether the in-hospital mortality rate differs between genders during the first 48 h after emergency percutaneous coronary intervention for ST-elevation myocardial infarction (emergency PCI-STEMI) or after non-emergency PCI. 
Introduction
Since the refinement of percutaneous coronary intervention (PCI) with techniques such as stent implantation and the development of drug-eluting stents, the PCI procedure is simpler and available in a larger number of hospitals. Recent advances in angioplasty have improved options for patients with smaller coronary arteries, and adjunctive pharmacotherapy has enhanced the outcomes of treatment in both women and men [1] . However, a number of studies have identified a very strong correlation between gender and mortality after PCI. The in-hospital mortality rate after myocardial infarction is higher among women than men [2, 3] , and female gender is considered to be a risk factor for complications after coronary angioplasty. Nevertheless, PCI is the recommended treatment for ST-segment elevation myocardial infarction (STEMI) in patients of both genders and for high-risk patients with acute coronary syndromes.
It has been suggested that the elevated mortality rate in women who receive PCI could be caused by an underdiagnosis or delayed diagnosis of acute coronary syndrome in women with non-fatal infarctions [4] , and a number of studies indicate that women are less likely to receive coronary angiography evaluations [4] [5] [6] . However, the relationship between gender and mortality is far from straightforward and probably evolves from a variety of closely linked factors. The results from a recent, large-cohort investigation suggest that the high mortality rate among women is caused primarily by less frequent performance of PCI [7] ; how-ever, several studies indicate that even among patients who receive PCI, adverse short-term outcomes (e.g., inhospital mortality, intraprocedural coronary artery injury, vascular complications) occur more frequently in women than in men [8] [9] [10] [11] [12] . This higher complication rate has been attributed primarily to greater age and disease severity, as well as differences in patient management and other clinical characteristics [10, 11] . To our knowledge, no study has described the gender-related very early mortality rate after PCI.
The investigation described here was designed to evaluate the relationship between gender and patient outcomes shortly after PCI. Specifically, we assessed whether inhospital death and morbidity are higher in women than in men during the first 48 h after emergency PCI for STEMI or after non-emergency PCI and whether women experienced in-hospital complications more frequently.
Methods

Patient population
All patients who receive PCI in both private and public hospitals are registered prospectively and consecutively into a database at the Regional Hospitalization Agency (MidiPyrenées, France), which evaluates the quality of care provided to patients treated with angioplasty. The data used in this investigation was extracted from the database and related to 9089 patients treated by PCI in our hospital (Rangueil University Hospital, Toulouse, France) during a 3.5-year period (January 2005 to June 2008). Data from all patients who received PCI were included in our analyses; there were no exclusion criteria. Patients who were in the hospital for less than 48 h were contacted by phone. Demographic information, diagnoses and 48-hour outcomes were entered in a uniform registry format and then sent mandatorily to the Regional Hospitalization Agency for all patients.
Data were analysed for two patient categories: emergency PCI-STEMI (i.e., patients admitted with STEMI who received primary emergency PCI or rescue emergency PCI after thrombolysis failed) and non-emergency PCI (i.e., patients who received non-emergency PCI for acute coronary syndromes or stable angina). The decision to perform emergency PCI was based on guidelines established by the American Heart Association [13] . Primary emergency PCI was performed in patients presenting less than 12 h after the onset of chest pain or other symptoms, who were not administered thrombolysis therapy; rescue PCI was performed when thrombolysis was unsuccessful for 90 min after initiating bolus administration of the thrombolytic agent. STEMI was defined as typical acute chest pain with persistent (> 20 min) ST-elevation. Non-emergency procedures were performed in patients with non-ST-elevation acute coronary syndromes or as elective intervention in patients with stable coronary artery disease and proof of ischaemia. All PCI procedures were performed by senior interventional cardiologists via standard techniques, including balloon angioplasty, stent implantation, and (when debulking was necessary) mechanical rotational atherectomy. Adjunctive medications for PCI were administered in agreement with the European Society of Cardiology guidelines [14] .
Study variables and endpoints
The primary endpoint of this study was the frequency of cardiac or non-cardiac death within 48 h after completion of the PCI procedure; information on outcomes after discharge was not available. Secondary endpoints included the frequency of recurrent myocardial infarction, new PCI or coronary artery bypass graft (CABG), stroke, and major vascular or renal complications; the occurrence of any secondary endpoint was also calculated. A diagnosis of recurrent myocardial infarction was based on recurrent chest pain (> 20 min) accompanied by re-elevation of cardiac enzyme levels and/or new ST-segment elevation determined via electrocardiography. Major vascular events were defined as any vascular access site complication that required surgical vascular repair or blood transfusion. Stroke was defined as the occurrence of persistent specific neurological deficits. Major renal events were defined as acute renal failure that required renal haemodialysis.
Statistical methods
Data for the emergency PCI-STEMI and non-emergency PCI groups were analysed separately. Statistical analyses were performed with SAS statistical software, version 9.2 (SAS Institute Inc., Cary, NC, USA). A p value less than 0.05 was considered statistically significant. Mean values for age were compared with the Student's t-test after verification of the distribution of residuals and the homogeneity of variances. For bivariate analyses, the distribution of qualitative variables was assessed with the 2 test. The Fisher's exact test was computed as needed. Analyses stratified for age (< or ≥ 75 years) and history of renal failure were performed with the Cochran-Mantel-Haenszel (CMH) test. Independent associations between gender and in-hospital outcome were assessed via multivariate logistic regression. Systematic adjustments were performed for age, history of coronary artery disease, renal failure, year of procedure, number of vessels affected and number of vessels treated.
To mitigate differences in baseline characteristics, pair analyses were performed via a propensity-score weighting method [15] , which can reduce bias in measured characteristics. A single propensity score was calculated to represent the relationship between an outcome and several characteristics, then a sequential matching pair analysis, from five to three digits of the predicted probability, was performed with patients of each gender who had equivalent propensity scores. The probability (i.e., the odds ratio [OR] ) that the event occurred in women rather than in men was calculated via logistic regression.
Results
Patient population and basic characteristics
More than 9000 patients were included: 1753 patients in the emergency PCI-STEMI group and 7336 patients in the non-emergency PCI group (Fig. 1) ; less than 10% of patients Table 1 . The proportions of women in the emergency PCI-STEMI group (23.4%) and the non-emergency PCI group (22.7%) were similar. In both groups, women were older than men (p < 0.0001) and more frequently had a history of renal failure (p < 0.0001), but men were more likely to have a history of coronary artery disease and previous PCI; in the nonemergency PCI group, men were more likely than women to have a history of myocardial infarction or CABG. All other baseline characteristics were similar between genders, and there were no significant differences in the proportions of men and women with multi-vessel disease, in the number of vessels treated or in the use of thrombolytic therapy. After propensity-score matching, baseline characteristics of men and women were similar in both PCI groups (data not shown).
In-hospital endpoint analyses
In the emergency PCI-STEMI group, the primary endpoint analysis indicated that a significantly smaller (p = 0.004) proportion of men (2.2%) than women (4.9%) died within 48 h of the procedure; however, the 48-hour mortality rate did not differ significantly (p = 0.77) between men (0.4%) and women (0.5%) in the non-emergency PCI group (Fig. 2) . After adjustment for age, history of coronary artery disease, renal failure, year of procedure, number of diseased or treated vessels and thrombolytic therapy ( Among patients aged ≥ 75 years (Table 3 ) who received emergency PCI for treatment of STEMI, the 48-hour mortality rate was significantly greater (p = 0.02) in women (8.1%) than in men (3.3%), and the 48-hour mortality risk remained greater for women after adjusting for age, history of coronary artery disease, renal failure, year of procedure, number of diseased or treated vessels and thrombolytic therapy; the 48-hour mortality rate and risk were similar between genders for patients aged less than 75 years (women, 1.9%; men, 1.8%; p = 1.0; CMH test, p = 0.05). In addition, for patients in the emergency PCI-STEMI group who had a history of renal failure (Table 3) , the 48-hour mortality rate was greater in women (11.4%) than in men (5.5%), and a stratified analysis linked renal failure to greater 48-hour mortality in women (CMH test; p = 0.03). In the non- emergency PCI group, there were no significant differences between men and women after stratification according to history of renal failure or age.
The occurrence of any individual secondary endpoint (i.e., recurrent myocardial infarction, new PCI or CABG, stroke, or vascular and renal complications) did not differ significantly between genders in either PCI group, and neither did a composite outcome that included all secondary endpoints but excluded death (emergency PCI-STEMI: men 2.0%, women, 2.4%, p = 0.59; non-emergency PCI: men 0.7%, women 1.1%, p = 0.07) ( Table 4 ). These results emphasize that death is the most common major adverse event to occur during the 48-hour period immediately after PCI. No correlation was found between the 48-hour mortality rate and occurrence of minor and major vascular complications.
Endpoint analyses after propensity-score matching
After propensity-score matching, the risk of death within 48 h after PCI was evaluated for 395 male-female matched pairs in the emergency PCI-STEMI group and 1658 male-female matched pairs in the non-emergency PCI group. For the emergency PCI-STEMI group, the 48-hour mortality risk was nearly threefold greater in women than in men (OR 2.80, 95% CI 1.16-6.74, p = 0.03) ( Table 5) , and this discrepancy increased to more than fivefold after adjustment for age, history of coronary artery disease, renal failure, year of procedure, number of diseased or treated vessels and thrombolytic therapy (OR 5.22, 95% CI 1.48-18.4, p = 0.02). Stratification by age indicated that the difference between genders occurred exclusively in patients aged ≥ 75 years; women in this age category were fivefold more likely than men to die within 48 h after PCI (unadjusted OR 5.18, 95% CI 1.47-18.2, p = 0.01; adjusted OR 5.68, 95% CI 1.54-20.9, p = 0.009), but there was no difference between genders for patients aged less than 75 years. The 48-hour mortality risk did not differ between genders in the non-emergency PCI group, and the composite outcome of secondary endpoints (excluding death) did not differ between genders in either PCI group (data not shown).
Discussion
Our findings indicate that female gender was not a risk factor for 48-hour, in-hospital mortality in patients aged less than 75 years or in patients who were treated in non-emergency situations. However, the results of this investigation indicate that the risk of death within 48 h after emergency PCI for treatment of STEMI is higher among women than among men. Fewer than 10% of patients in the emergency PCI-STEMI group were referred for emergency PCI after thrombolysis failed; thus, the gender disparity in 48-hour mortality probably occurred after primary angioplasty procedures. The discrepancy remained significant after standard multivariate adjustment for confounders and in paired analyses of men and women with matching propensity scores; however, it was restricted to patients aged ≥ 75 years and was not observed for non-emergency procedures. Adverse events were also more common in women than in men after emergency PCI for treatment of STEMI, but the frequency of major cardiac, vascular and renal events (excluding death) were rare and did not differ between genders, even among older patients. The gender disparity in cardiac diagnosis and treatment has been recognized since 1991, when Ayanian and Epstein [16] first reported that women were less likely than men to undergo diagnostic coronary angiography and coronary revascularization for the treatment of heart disease. A recent large cohort from the Get With The Guidelines initiative in the USA confirmed that women were less likely than men to receive reperfusion therapy and guidelinesbased medical therapy after acute myocardial infarction [17] . However, recent evidence also indicates that gender bias persists in the referral of patients for coronary angiography but not in the subsequent use of coronary revascularization or in the pharmacological treatment of acute myocardial infarction [18] . As all patients included in our analyses underwent PCI (main difference with previous studies), the gender-dependent disparity in patient mortality reported here was probably not caused by discrepancies in patient care. Within the emergency PCI-STEMI group, women were older than men and were more likely to have a history of renal failure. Similar observations have been reported previously [9, 10] and may contribute to the less favourable in-hospital outcomes observed in women than in men who receive PCI [10] [11] [12] . Our results indicate that the frequency of 48-hour mortality remained higher among women than men after adjusting for age or history of renal failure, in pair analyses of men and women with similar age and medical history, and in patients aged ≥ 75 years. Thus, the gender discrepancy in 48-hour mortality cannot be attributed entirely to differences in age or in the prevalence of renal failure.
Because the higher risk of death in women than in men who present with acute myocardial infarction persisted in analyses of matched male-female pairs and after adjustment for age, history of coronary artery disease, renal failure, and the number of diseased or treated vessels, it cannot be linked to greater anatomical or physiological frailty among women. A more plausible explanation could implicate differences in the initial presentation of acute coronary artery disease in men and women and, consequently, in the diagnosis of the disease and subsequent management of the patients. Diagnosis in women may be delayed, and women may be treated less vigorously during prehospital management, perhaps because of concerns about bleeding. Lastly, the time between symptom onset and hospital admission, and between hospital admission and the initiation of PCI, may be longer for women than men because myocardial infarction occurs at a more advanced age in women. Among community-based hospitals participating in the Get With The Guidelines initiative in the United States, the proportion of patients receiving primary PCI in compliance with the door-to-balloon standard of ≤ 90 min (as indicated in the American College of Cardiology/American Heart Association guidelines) has improved by 22.6% over the last 5 years. Nevertheless, door-to-balloon times remain longer for the elderly than younger patients and for women than men, even after adjusting for the presence of comorbid conditions [19] .
The 7-8-year age difference between men and women who experience their first STEMI could lead to gender discrepancies in patient management that contribute to the higher mortality rate observed in women; for example, thrombolytic drugs are less likely to be administered to elderly patients than to younger patients with acute myocardial infarction. Women may also be more likely to experience declines in renal function after PCI and may have a greater risk of contrast-induced nephropathy [20] . Nevertheless, the gender disparity in mortality persisted in pair analyses of men and women with matching propensity scores, and although a history of renal failure was associated with a twofold increase in mortality, the 48-hour mortality risk in patients with and without renal failure was still higher in women than in men. Gender discrepancies in treatment outcomes have also been attributed to humoral factors or to smaller vessel diameters and more frequent intimae dissections in women than men, but if so, we would expect to see differences in the occurrence of adverse events other than death, which were not apparent in our analyses.
Clinical implications
Although recent refinements in PCI technique have led to greater procedural success in men and women of all ages, the results presented here indicate that the risk of inhospital mortality during the first 48 h after PCI remains disproportionately high for elderly women who receive emergency procedures. Our analysis differs from those in previous reports because we focused on mortality during just the first 48 h after PCI and these data cannot be generalized to the entire female population with acute myocardial infarction. Contrary to our data, it has been recently reported by Champney et al. that the higher short-term mortality among women compared with men, after myocardial infarction, is confined to women aged less than 75 years. However, in their large retrospective study, only 30% of women were treated by primary PCI compared with 47% of men [21] . In our study, we were able to minimize any potential contribution from gender-specific differences in patient care, because all patients were referred for PCI. Because the French health-care system provides identical coverage and access to men and women regardless of social status, we believe that prevention campaigns and educational sessions about chest pain for patients with cardiovascular risk factors can improve patient outcomes, especially for women, by reducing the delay between symptom onset and the first call to a medical professional. By doing so, and giving the same access to PCI for women and men, we can expect similar short-term mortality rates, except among elderly women so far.
Study limitations
We acknowledge several limitations that restrict the interpretation of our study. This was an observational, uncontrolled study. Our findings are limited to in-hospital events (i.e., long-term outcomes were not evaluated) and could be influenced by a potential gender bias that occurred during selection of the patients' treatment regimens. All patients who received emergency PCI for treatment of STEMI or non-emergency PCI were included in our statistical analyses; there were no exclusion criteria. Substantial differences in the management of individual patients were unlikely, because all patients were treated at the same institution and the inclusion period was limited to 3.5 years. We acknowledge that limiting inclusion to a single institution could bias patient selection; however, our data are similar to the data collected by the coronary heart disease registry for the entire geographical region [22] ; this similarity suggests that patient selection was not biased. Data about cardiovascular risk factors and previous treatment before PCI were not available. In particular, we could not obtain data on the duration of ischaemia (pain-to-door time and door to-balloon time), adjunctive treatment (including glycoprotein IIb/IIIa inhibitors), reperfusion quality after PCI or ejection fraction, which would have affected the prognosis. These factors are important as they may be used as predictors to explain differences in cardiac prognosis. Thus, our study did not elucidate the cause of this abnormal high death rate. However, our analytical approach using both a propensity score adjustment and a conventional covariate adjustment in the logistic regression models yielded similar point estimates and 95% confidence limits for the magnitude of association of gender and mortality risk.
Conclusion
Elderly women who undergo emergency PCI for treatment of STEMI have a disproportionately high in-hospital mortality rate during the first 48 h after the procedure. However, there is no gender discrepancy in younger patients or in patients of any age who receive non-emergency procedures. Major adverse events, including renal and vascular complications, occurred at similar rates in men and women after emergency or non-emergency PCI.
